Arrowhead Pharmaceuticals Stock Price Patterns
| ARWR Stock | USD 69.33 0.21 0.30% |
Momentum 49
Impartial
Oversold | Overbought |
Quarterly Earnings Growth 0.098 | EPS Estimate Next Quarter 0.045 | EPS Estimate Current Year (3.31) | EPS Estimate Next Year (4.39) | Wall Street Target Price 81.9167 |
Using Arrowhead Pharmaceuticals hype-based prediction, you can estimate the value of Arrowhead Pharmaceuticals from the perspective of Arrowhead Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Arrowhead Pharmaceuticals using Arrowhead Pharmaceuticals' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Arrowhead using crowd psychology based on the activity and movement of Arrowhead Pharmaceuticals' stock price.
Arrowhead Pharmaceuticals Short Interest
An investor who is long Arrowhead Pharmaceuticals may also wish to track short interest. As short interest increases, investors should be becoming more worried about Arrowhead Pharmaceuticals and may potentially protect profits, hedge Arrowhead Pharmaceuticals with its derivative instruments, or be ready for some potential downside.
200 Day MA 32.9687 | Short Percent 0.1052 | Short Ratio 4.02 | Shares Short Prior Month 9.6 M | 50 Day MA 62.6046 |
Arrowhead Pharmaceuticals Hype to Price Pattern
Investor biases related to Arrowhead Pharmaceuticals' public news can be used to forecast risks associated with an investment in Arrowhead. The trend in average sentiment can be used to explain how an investor holding Arrowhead can time the market purely based on public headlines and social activities around Arrowhead Pharmaceuticals. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Arrowhead Pharmaceuticals' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Arrowhead Pharmaceuticals.
Arrowhead Pharmaceuticals Implied Volatility | 1.45 |
Arrowhead Pharmaceuticals' implied volatility exposes the market's sentiment of Arrowhead Pharmaceuticals stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Arrowhead Pharmaceuticals' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Arrowhead Pharmaceuticals stock will not fluctuate a lot when Arrowhead Pharmaceuticals' options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in Arrowhead Pharmaceuticals to buy its stock at a price that has no basis in reality. In that case, they are not buying Arrowhead because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Arrowhead Pharmaceuticals after-hype prediction price | USD 66.94 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Prediction based on Rule 16 of the current Arrowhead contract
Based on the Rule 16, the options market is currently suggesting that Arrowhead Pharmaceuticals will have an average daily up or down price movement of about 0.0906% per day over the life of the 2026-03-20 option contract. With Arrowhead Pharmaceuticals trading at USD 69.33, that is roughly USD 0.0628 . If you think that the market is fully incorporating Arrowhead Pharmaceuticals' daily price movement you should consider acquiring Arrowhead Pharmaceuticals options at the current volatility level of 1.45%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Arrowhead | Build AI portfolio with Arrowhead Stock |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Arrowhead Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Arrowhead Pharmaceuticals After-Hype Price Density Analysis
As far as predicting the price of Arrowhead Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Arrowhead Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Arrowhead Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Arrowhead Pharmaceuticals Estimiated After-Hype Price Volatility
In the context of predicting Arrowhead Pharmaceuticals' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Arrowhead Pharmaceuticals' historical news coverage. Arrowhead Pharmaceuticals' after-hype downside and upside margins for the prediction period are 61.87 and 72.01, respectively. We have considered Arrowhead Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Arrowhead Pharmaceuticals is very steady at this time. Analysis and calculation of next after-hype price of Arrowhead Pharmaceuticals is based on 3 months time horizon.
Arrowhead Pharmaceuticals Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Arrowhead Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Arrowhead Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Arrowhead Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
1.03 | 5.07 | 2.39 | 1.85 | 7 Events / Month | 7 Events / Month | In about 7 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
69.33 | 66.94 | 3.45 |
|
Arrowhead Pharmaceuticals Hype Timeline
Arrowhead Pharmaceuticals is presently traded for 69.33. The entity has historical hype elasticity of -2.39, and average elasticity to hype of competition of 1.85. Arrowhead is anticipated to decline in value after the next headline, with the price expected to drop to 66.94. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -3.45%, whereas the daily expected return is presently at 1.03%. The volatility of related hype on Arrowhead Pharmaceuticals is about 282.29%, with the expected price after the next announcement by competition of 71.18. About 83.0% of the company shares are held by institutions such as insurance companies. The company has Price/Earnings (P/E) ratio of 482.39. Arrowhead Pharmaceuticals recorded a loss per share of 0.01. The entity last dividend was issued on the 29th of October 2010. The firm had 1:10 split on the 17th of November 2011. Given the investment horizon of 90 days the next anticipated press release will be in about 7 days. Check out Arrowhead Pharmaceuticals Basic Forecasting Models to cross-verify your projections.Arrowhead Pharmaceuticals Related Hype Analysis
Having access to credible news sources related to Arrowhead Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Arrowhead Pharmaceuticals' future price movements. Getting to know how Arrowhead Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Arrowhead Pharmaceuticals may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| PCVX | Vaxcyte | (0.88) | 9 per month | 2.48 | 0.09 | 6.38 | (3.46) | 15.14 | |
| CRSP | Crispr Therapeutics AG | 0.59 | 11 per month | 0.00 | (0.11) | 5.31 | (5.47) | 19.81 | |
| PTCT | PTC Therapeutics | 11.49 | 22 per month | 2.10 | 0.07 | 3.88 | (3.49) | 13.88 | |
| ACLX | Arcellx | (0.79) | 9 per month | 0.00 | (0.09) | 4.75 | (4.57) | 22.18 | |
| KRYS | Krystal Biotech | 6.90 | 7 per month | 1.08 | 0.26 | 4.46 | (2.43) | 10.86 | |
| TGTX | TG Therapeutics | (1.62) | 11 per month | 0.00 | (0.07) | 3.96 | (3.85) | 11.58 | |
| ALKS | Alkermes Plc | 0.54 | 9 per month | 1.99 | 0.1 | 3.82 | (2.30) | 11.41 | |
| AXSM | Axsome Therapeutics | (0.94) | 11 per month | 1.19 | 0.16 | 4.20 | (2.36) | 26.78 | |
| MTSR | Metsera Common Stock | (0.13) | 8 per month | 2.40 | 0.17 | 14.25 | (4.09) | 75.60 | |
| KYMR | Kymera Therapeutics | 2.80 | 9 per month | 2.64 | 0.08 | 4.40 | (4.46) | 49.42 |
Arrowhead Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine Arrowhead price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Arrowhead using various technical indicators. When you analyze Arrowhead charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Arrowhead Pharmaceuticals Predictive Indicators
The successful prediction of Arrowhead Pharmaceuticals stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Arrowhead Pharmaceuticals, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Arrowhead Pharmaceuticals based on analysis of Arrowhead Pharmaceuticals hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Arrowhead Pharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Arrowhead Pharmaceuticals's related companies. | 2010 | 2011 | 2025 | 2026 (projected) | Payables Turnover | 0.0261 | 0.54 | 0.48 | 0.51 | Days Of Inventory On Hand | 214.36 | 54.6K | 49.1K | 51.6K |
Pair Trading with Arrowhead Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Arrowhead Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arrowhead Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.Moving against Arrowhead Stock
| 0.94 | ACLX | Arcellx | PairCorr |
| 0.81 | EVGN | Evogene | PairCorr |
| 0.8 | RANI | Rani Therapeutics | PairCorr |
| 0.76 | APLT | Applied Therapeutics | PairCorr |
| 0.74 | CRBP | Corbus Pharmaceuticals | PairCorr |
| 0.68 | MBIO | Mustang Bio | PairCorr |
The ability to find closely correlated positions to Arrowhead Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Arrowhead Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Arrowhead Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Arrowhead Pharmaceuticals to buy it.
The correlation of Arrowhead Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Arrowhead Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Arrowhead Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Arrowhead Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Arrowhead Stock Analysis
When running Arrowhead Pharmaceuticals' price analysis, check to measure Arrowhead Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arrowhead Pharmaceuticals is operating at the current time. Most of Arrowhead Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Arrowhead Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arrowhead Pharmaceuticals' price. Additionally, you may evaluate how the addition of Arrowhead Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.